Although resistin was initially associated with metabolic disorders, increased levels of resistin and its positive correlation with inflammatory markers and disease activity have been previously demonstrated in patients with rheumatoid arthritis (RA) [4,18-20]. The gene discussed is RETN; the disease is metabolic disease.